THERAPEUTICS
Review: vitamin D supplementation decreases all-cause mortality in adults and older people
| The first 150 words of the full text of this article appear below. |
P Autier
Dr P Autier, International Agency for Research on Cancer, Lyon, France; autierp@iacr.fr
REVIEW PROCESS
what is the effect of vitamin D supplementation on all-cause mortality?
PubMed, ISI Web of Science (Science Citation Index Expanded), EMBASE/Excerpta Medica, Cochrane Library, and bibliographies of selected studies, reviews, or books (to November 2006).
principal published reports of randomised controlled trials (RCTs) that assessed the effects of vitamin D supplementation (vitamin D2 [ergocalciferol] or vitamin D3 [cholecalciferol]), taken for any condition, on all-cause mortality. Trials had to randomise participants on an individual (rather than cluster) basis and include sufficient information to allow for calculation of relative risks and 95% CIs for all-cause mortality for vitamin D supplementation v placebo or control. Trials that evaluated treatment with 1
hydroxyvitamin D3 (alfacalcidol), 1
,25 dihydroxyvitamin D3 (calcitriol), or other vitamin D analogues in patients with advanced prostate cancer, chronic or end stage renal disease, or those on
San Francisco Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, California, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
